Gestar
Gestar is a São Paulo-based fetal medicine and intrauterine surgery clinic offering advanced prenatal diagnostics and minimally invasive fetal surgeries for high-risk pregnancies, staffed by 9 subspecialists led by Dr. Fábio Peralta with surgical affiliations at HCOR, Hospital São Luiz, and CETRUS.
- Company typePrivate
- Founded2020
- HeadquartersSão Paulo, Brazil
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Gestar does
Gestar Centro de Medicina e Cirurgia Fetal is a specialized fetal medicine and intrauterine surgery clinic headquartered in São Paulo, Brazil. It provides a comprehensive portfolio of advanced prenatal diagnostic services (morphological ultrasound at first and second trimester with Doppler, fetal echocardiography with 3D/4D techniques, fetal biophysical profiling, cardiotocography, amniocentesis, chorionic villus sampling, cordocentesis, and thoracentesis) and intrauterine surgical interventions (myelomeningocele repair via a proprietary 2.5 cm mini-hysterotomy technique, fetoscopic laser ablation for twin-twin transfusion syndrome and selective fetal growth restriction, fetoscopic tracheal occlusion for severe congenital diaphragmatic hernia, endoscopic urethral valve destruction, thoraco-amniotic and nephro-amniotic drain placement, intrauterine blood transfusion, and experimental third ventriculostomy).
The practice is led by Dr. Cleisson Fábio Andrioli Peralta, an obstetrician and fetal surgeon trained at King's College Hospital London, supported by a team of 9 subspecialists covering maternal-fetal medicine, fetal echocardiography, general and vascular ultrasound, and endometriosis imaging. Surgical procedures are performed at affiliated hospitals including Hospital do Coração (HCOR), Hospital São Luiz, Hospital Santa Marcelina, and CETRUS. The practice coordinates the Rede Gestar de Medicina Materno-Fetal network and the postgraduate fetal medicine training program at CETRUS.
Gestar operates a direct-to-consumer and physician-referral model, generating revenue from per-consultation and per-procedure professional services billed to patients or insurers. Patients reach the practice via obstetrician referrals, hospital affiliations, national media exposure of the lead surgeon (Fantástico, CNN Brasil), a dedicated WhatsApp direct line, and individual physician booking pages on the clinicadigital.tisaude.com platform. The website's fetal surgery counter currently reads zero, indicating either recent reset or limited public tracking of surgical volume. No external investment, funding rounds, or parent company ownership is disclosed; the practice appears to be a physician-led collaborative group.
Gestar firmographics
Firmographics- Name
- Gestar
- Legal name
- Gestar Centro de Medicina Fetal
- Website
- https://gestarcmf.com.br
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Gestar is a São Paulo-based fetal medicine and intrauterine surgery clinic offering advanced prenatal diagnostics and minimally invasive fetal surgeries for high-risk pregnancies, staffed by 9 subspecialists led by Dr. Fábio Peralta with surgical affiliations at HCOR, Hospital São Luiz, and CETRUS.
- Ownership category
- akta.pro rank
Gestar industry classification
Industry- Product category
- Fetal Medicine and Surgery
- NAICS
- Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro industry
- Maternal-Fetal Medicine (High-Risk Pregnancy/Perinatology)Maternal-Fetal Medicine (High-Risk Pregnancy) CentersPrenatal & Maternal-Fetal Diagnostic Imaging CentersMinimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy)
Keywords
Where Gestar is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Gestar business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Consultations and Diagnostic Exams: Revenue generated from fetal medicine consultations, ultrasound examinations, cardiotocography, fetal echocardiography, and other diagnostic services billed per procedure or consultation session
- Fetal Surgical Procedures: Revenue from intrauterine surgical interventions including myelomeningocele repair, laser ablation for twin-twin transfusion, fetoscopic tracheal occlusion, cordocentesis transfusions, thoracentesis, and urinary tract decompression procedures
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Gestar product offering
Product offeringCore offering
Gestar Centro de Medicina e Cirurgia Fetal is a specialized fetal medicine and surgery practice based in São Paulo, Brazil, offering a comprehensive portfolio of fetal diagnostic examinations (obstetric ultrasound, Doppler, morphological first/second trimester screening, fetal echocardiography, cardiotocography, amniocentesis, chorionic villus sampling, cordocentesis, thoracentesis) and intrauterine surgical procedures (myelomeningocele repair via mini-hysterotomy, fetoscopic laser ablation for twin-twin transfusion syndrome, fetoscopic tracheal occlusion for diaphragmatic hernia, endoscopic urethral valve destruction, nephro-amniotic and thoraco-amniotic drain placement, intrauterine blood transfusion, and third ventriculostomy). The practice is coordinated by Dr. Fábio Peralta with a team of 9 subspecialists and operates in partnership with major São Paulo hospitals.
Product overview
Gestar Centro de Medicina e Cirurgia Fetal is a specialized fetal medicine clinic in São Paulo, Brazil, offering a comprehensive portfolio of fetal diagnostic examinations and intrauterine surgical procedures. The offering consists of two integrated service lines: (1) Diagnostic examinations including obstetric ultrasound (standard, morphological first/second trimester, Doppler, 3D/4D), fetal echocardiography (ecodopplercardiograma), biophysical profiling, cardiotocography, amniocentesis, chorionic villus sampling, cordocentesis, and thoracentesis; and (2) Fetal surgeries including myelomeningocele correction via mini-hysterotomy, fetoscopic laser ablation for twin-twin transfusion syndrome and selective growth restriction, tracheal occlusion for diaphragmatic hernia, endoscopic urethral valve destruction, nephro-amniotic drains, thoraco-amniotic drains, third ventriculostomy, and intrauterine blood transfusions. The clinic is coordinated by Dr. Fábio Peralta and operates in partnership with Hospital do Coração (HCor), Hospital São Luiz, and CETRUS. Services are delivered by a team of maternal-fetal medicine specialists, obstetric surgeons, and fetal echocardiographers.
Differentiator
Problem solved
Functional benefit
Products and services
- Mielomeningocele (MMC) / Spina Bifida Correction Surgery Open fetal surgery to correct myelomeningocele (spina bifida) via a modified mini-hysterotomy technique (2.5 cm incision), reducing maternal risks and preterm birth compared to the standard MOMs trial technique, performed between 19-26 weeks gestation.
- Twin-Twin Transfusion Syndrome (TTTS) Laser Ablation Fetoscopic laser ablation surgery to cauterize communicating placental vessels in twin-twin transfusion syndrome, lasting approximately 60 minutes under spinal anesthesia, with an 80% chance of at least one twin surviving.
- High Urinary Tract Obstruction - Nephro-Amniotic Drain Placement Placement of nephro-amniotic drains to allow fetal urine to exit and accumulate in the amniotic sac, improving lung development and survival from 0% to 50% in cases of high-grade fetal urinary obstruction.
- Low Urinary Tract Obstruction - Endoscopic Urethral Valve Destruction Endoscopic surgery using a balloon catheter to rupture the posterior urethral valve membrane and dilate the urethra in male fetuses with lower urinary tract obstruction, performed at under 26 weeks gestation.
- Fetal Anemia - Intrauterine Blood Transfusion (Cordocentesis) Intravascular blood transfusion directly into the fetal umbilical cord for treatment of moderate to severe fetal anemia (PVS > 1.5 MoM), performed between 18-34 weeks, with 70-90% fetal survival rates.
- Congenital Diaphragmatic Hernia - Fetal Tracheal Occlusion (FETO) Fetoscopic endoluminal tracheal occlusion with balloon placement to promote fetal lung expansion in severe congenital diaphragmatic hernia, improving survival from 10% to 50%, followed by balloon removal at 32-34 weeks.
- Fetal Pleural Effusion - Thoraco-Amniotic Drain Placement Placement of thoraco-amniotic drains to drain accumulated fluid from the fetal pleural cavity in cases of fetal pleural effusion, improving perinatal survival from 25% to 70% when accompanied by hydrops.
- TRAP Sequence - Laser Interruption of Placental Vessels Laser interruption of blood flow between the normal fetus and the acardiac twin in TRAP sequence, increasing the chance of the normal fetus surviving to 76%.
- Selective Fetal Growth Restriction Surgery Laser ablation of placental vessels to separate the circulation of fetuses with selective intrauterine growth restriction and severe blood flow alterations (zero diastolic flow), protecting the larger fetus.
- Severe Cerebral Ventriculomegaly - Third Ventriculostomy Experimental fetal endoscopic third ventriculostomy under spinal anesthesia to perforate the floor of the third cerebral ventricle, draining accumulated cerebrospinal fluid to reduce hydrocephalus and brain damage.
- Congenital Cystic Adenomatoid Malformation (CCAM) - Thoraco-Amniotic Drain Thoraco-amniotic drain placement for cystic adenomatoid malformation of the lungs, draining pulmonary cysts to improve fetal lung development and survival to approximately 78%.
- Amniocentesis Collection of amniotic fluid for evaluation of fetal chromosome number and structure (fetal karyotype).
- Chorionic Villus Sampling Collection of placental tissue for evaluation of fetal chromosome number and structure (fetal karyotype).
- Cordocentesis Umbilical cord blood sampling for investigation of chromosomal anomalies, infections, anemia, and thrombocytopenia; also used to perform intrauterine blood transfusions and administer medications for specific cardiac rhythm abnormalities.
- Thoracentesis Pleural fluid collection from the fetal chest for diagnostic and therapeutic purposes, and drainage of cystic lung lesions, performed after 20 weeks gestation.
- First Trimester Morphological Ultrasound (Nuchal Translucency) First trimester morphological ultrasound / nuchal translucency examination performed between 11-13 weeks and 6 days to evaluate fetal anatomy, confirm gestational age, and calculate risks for chromosomal anomalies, preeclampsia, and intrauterine growth restriction.
- Second Trimester Morphological Ultrasound Second trimester morphological ultrasound examination performed between 18-24 weeks to assess fetal anatomy and growth, calculate risks for chromosomal anomalies, preeclampsia, and intrauterine growth restriction, with approximately 90% diagnostic accuracy.
- Obstetric Ultrasound with Doppler Obstetric ultrasound with Doppler evaluation to assess blood circulations between the fetus and placenta and between the mother and placenta, typically performed in the second half of pregnancy.
- Standard Obstetric Ultrasound Standard obstetric ultrasound to evaluate fetal anatomy, growth, position, and presentation, as well as amniotic fluid quantity, placental position, and characteristics.
- Fetal Echocardiography (Ecodopplercardiograma) Fetal echocardiography with Doppler and 3D imaging to identify and define anatomy and hemodynamic behavior of congenital heart defects, performed between 20-30 weeks (ideally around 28 weeks).
- Fetal Biophysical Profile Fetal well-being assessment combining ultrasound and cardiotocography to evaluate fetal tone, body movement, breathing movement, cardiac reactivity, and amniotic fluid volume, performed in the third trimester.
- Antepartum Cardiotocography Antepartum cardiotocography for fetal heart rate monitoring to assess fetal well-being.
Quantifiable outcome
- Approximately 90% of fetal diseases diagnosed through second-trimester morphological ultrasound
- +7 more outcomes
Companies that use Gestar
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Gestar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Gestar partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Hospital do Coração (HCOR)coreDr. Fábio Peralta serves as the physician responsible for Fetal Surgery at Hospital do Coração (HCOR) in São Paulo. The hospital is listed as a key partner with its logo displayed on Gestar's website. Multiple Gestar physicians (Dr. Rafael Botelho, Dr. Karina Jorge Rodrigues) also provide obstetric services at HCOR, indicating a deep clinical integration for patient delivery and postnatal care following fetal interventions.
- CETRUS - Escola de UltrassonografiacoreCETRUS (School of Ultrasound) is listed as a partner with its logo on the Gestar website. Dr. Peralta serves as the coordinating physician for the fetal medicine improvement program (postgraduate lato sensu) at CETRUS São Paulo. Several Gestar physicians completed their fetal medicine and ultrasound specializations through CETRUS, creating a training and academic partnership.
- Hospital São Luiz (São Paulo)coreDr. Fábio Peralta is listed as the physician responsible for Fetal Surgery at Hospital São Luiz in São Paulo, one of the major private hospital networks in Brazil. This provides surgical facility access for fetal procedures with postnatal care capabilities.
- Hospital Santa MarcelinacoreDr. Rafael Davi Botelho serves as the physician in charge of the Obstetrics and Obstetric Pathology service at Hospital Santa Marcelina's Department of Women's Health. Multiple Gestar physicians trained at Hospital Santa Marcelina (residency programs), creating ongoing clinical affiliations for patient care continuity.
- Rede Gestar de Medicina Materno-FetalcoreGestar is part of the 'Rede Gestar de Medicina Materno-Fetal' (Gestar Network of Maternal-Fetal Medicine), a multi-center fetal medicine network. Dr. Peralta coordinates the fetal surgery group of this network, which has performed procedures on thousands of patients worldwide with excellent results, particularly for twin-twin transfusion syndrome laser ablation.
Scale indicators13 records
Recent moves6 records
Expansion highlights5 records
Gestar competitors and assessment
Company assessmentBroad incumbents
- DASA (Diagnósticos da América): Largest medical diagnostics company in Latin America, operating imaging and laboratory networks including obstetric ultrasound. Competes with Gestar for prenatal diagnostic referrals in São Paulo through brands like Delboni and Alta.
- Hospital das Clínicas da FMUSP – Setor de Medicina Fetal: The largest academic public hospital in São Paulo, with a fetal medicine sector where several Gestar-affiliated physicians trained. Provides competing fetal diagnostic and surgical services to SUS patients and trains the next generation of specialists, overlapping with Gestar's pipeline.
- Fleury Medicina e Saúde: Brazil's largest diagnostic medicine company, offering obstetric ultrasound and prenatal diagnostics across São Paulo. Comparable on the diagnostic side of Gestar's business; not a fetal surgery competitor but competes for OB imaging referrals.
- Hospital Sírio-Libanês – Medicina Fetal: Another leading São Paulo private hospital offering specialized fetal medicine diagnostics and intrauterine procedures. Competes with Gestar for affluent high-risk pregnancy referrals, with the advantage of an integrated multi-specialty hospital system.
- Hospital Israelita Albert Einstein – Centro de Medicina Fetal: One of Brazil's most prestigious private hospital systems, Einstein operates a fetal medicine center in São Paulo offering advanced prenatal diagnostics and fetal surgery. It competes with Gestar for the same premium OB patient base but as part of a much broader tertiary hospital portfolio.
Regional players
- Maternidade Pro Matre Paulista: Major private maternity hospital in São Paulo with prenatal diagnostic and high-risk pregnancy services. Indirectly comparable as it serves the same high-risk OB patient pool in São Paulo, though it does not focus exclusively on fetal surgery.
- Hospital e Maternidade Santa Joana: Large private maternity hospital in São Paulo focused on high-risk pregnancies. Competes with Gestar for premium OB referrals and offers advanced ultrasound and fetal diagnostics, though it is less specialized in intrauterine surgery.
Direct peers
- Texas Children's Fetal Center: Major US-based fetal surgery and therapy center affiliated with Baylor College of Medicine. Performs the same set of intrauterine procedures as Gestar (myelomeningocele repair, TTTS, FETO, etc.) and serves as a benchmark for case volume and outcomes in the field.
- Children's Hospital of Philadelphia (CHOP) – Center for Fetal Diagnosis and Treatment: One of the world's leading fetal surgery centers, performing open and fetoscopic procedures including myelomeningocele repair, TTTS laser, FETO, and EXIT. A direct global peer in capability and case mix, though at a much larger scale.
Others
- Fetal Medicine Foundation: UK-based international body that certifies fetal medicine specialists and accredits ultrasound training programs. Gestar's lead physician holds the FMF international specialist title; FMF is an ecosystem/credentialing peer rather than a direct competitor.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Gestar social profiles
Digital presenceGestar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Gestar leadership team
Management profileNumber of profiles
Profiles9 records
Gestar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Gestar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Gestar
What does Gestar do?
Gestar Centro de Medicina e Cirurgia Fetal is a specialized fetal medicine and surgery practice based in São Paulo, Brazil, offering a comprehensive portfolio of fetal diagnostic examinations (obstetric ultrasound, Doppler, morphological first/second trimester screening, fetal echocardiography, cardiotocography, amniocentesis, chorionic villus sampling, cordocentesis, thoracentesis) and intrauterine surgical procedures (myelomeningocele repair via mini-hysterotomy, fetoscopic laser ablation for twin-twin transfusion syndrome, fetoscopic tracheal occlusion for diaphragmatic hernia, endoscopic urethral valve destruction, nephro-amniotic and thoraco-amniotic drain placement, intrauterine blood transfusion, and third ventriculostomy). The practice is coordinated by Dr. Fábio Peralta with a team of 9 subspecialists and operates in partnership with major São Paulo hospitals.
Is Gestar a public or private company?
Gestar is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Gestar founded?
Gestar was founded in 2020. It employs 11 to 50 people.
Where is Gestar based?
Gestar is headquartered in São Paulo, Brazil, in the Latin America region.
How does Gestar make money?
Two revenue lines are on record. Medical Consultations and Diagnostic Exams are the primary driver. The others are fetal Surgical Procedures.
Who are Gestar's main competitors?
Broad incumbents on record are DASA (Diagnósticos da América), Hospital das Clínicas da FMUSP – Setor de Medicina Fetal, Fleury Medicina e Saúde, Hospital Sírio-Libanês – Medicina Fetal and Hospital Israelita Albert Einstein – Centro de Medicina Fetal. Regional players are Maternidade Pro Matre Paulista and Hospital e Maternidade Santa Joana. Direct peers are Texas Children's Fetal Center and Children's Hospital of Philadelphia (CHOP) – Center for Fetal Diagnosis and Treatment. Fetal Medicine Foundation is listed as an others.
Does Gestar have an API?
No public API is recorded for Gestar.
What industry is Gestar in?
Gestar's product category is Fetal Medicine and Surgery. Its primary akta.pro industry code is HLAKAJAB, Maternal-Fetal Medicine (High-Risk Pregnancy/Perinatology), with a secondary code of HLAFAJAB, Maternal-Fetal Medicine (High-Risk Pregnancy) Centers. Its NAICS code is 621512 and its SIC code is 8011.